Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Clinical trial NCT04048876 · TERMINATED

Trial details

NCT number: NCT04048876
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-alcoholic Fatty Liver Disease Liver Cirrhosis

Start date: 2019-08-14
Primary completion: 2021-09-28
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.